ADVERTISEMENT

A First Step for a Family Biotech’s Vaccine Against Alzheimer’s

United Neuroscience’s small Phase II trial appears to have overcome a decades-old hurdle.

(Bloomberg Businessweek) -- For two decades, biotech companies trying to tackle Alzheimer’s disease have had little success. While vaccines have often shown promise for certain patients, they’ve come with devastating side effects for others—brain swelling, for example—because researchers haven’t been able to reliably keep patients’ immune systems from kicking into overdrive when exposed to the vaccines. Now, a four-year old Dublin s...
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More